Insider Trading activities of Tetraphase Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tetraphase Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tetraphase Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Tetraphase Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is TTPH. The reporting company's CIK number is 1373707.
The total value of stock buying since 2005 is $31,311,980.
The total value of stock sales since 2005 is $36,245,956.
The total value of stock option exercises since 2005 is $3,102,552.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Tetraphase Pharmaceuticals Inc (TTPH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 0 $0 24,655 $146,928 17,500 $64,575
2017-06 0 $0 0 $0 10,000 $20,299
2017-03 11,000 $82,280 0 $0 0 $0
2017-02 0 $0 0 $0 30,378 $88,096
2016-05 0 $0 0 $0 25,323 $22,031
2016-01 0 $0 0 $0 12,000 $10,440
2015-10 0 $0 0 $0 20,000 $40,599
2015-09 0 $0 20,000 $856,500 20,000 $223,900
2015-08 0 $0 84,500 $3,776,740 66,500 $436,119
2015-07 0 $0 52,500 $2,575,299 37,500 $281,586
2015-06 0 $0 76,086 $3,205,173 79,999 $637,283
2015-05 0 $0 65,000 $2,608,300 65,000 $622,749
2015-03 0 $0 10,000 $392,849 30,000 $96,800
2015-02 0 $0 10,000 $355,100 10,000 $79,400
2015-01 0 $0 34,135 $1,248,965 34,135 $142,001
2014-10 0 $0 247,734 $5,138,724 0 $0
2014-09 0 $0 572,266 $9,876,484 20,000 $28,999
2014-08 0 $0 10,000 $115,900 35,000 $30,450
2014-07 0 $0 15,000 $159,105 40,000 $34,800
2014-06 1,975 $20,761 228,530 $3,049,006 15,000 $13,050
2014-05 30,850 $286,320 15,000 $135,000 15,000 $13,050
2014-04 0 $0 15,000 $145,350 15,000 $13,050
2014-03 0 $0 16,004 $204,201 0 $0
2014-02 0 $0 52,422 $741,226 103,391 $158,276
2014-01 0 $0 0 $0 51,724 $44,999
2013-09 0 $0 153,468 $1,515,106 0 $0
2013-03 4,417,517 $30,922,619 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Tetraphase Pharmaceuticals Inc insiders (TTPH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-22 Dumas Jacques (Chief ScientificOfficer) Sale 17,500 6.00 105,000
2017-08-22 Dumas Jacques (Chief ScientificOfficer) Option Ex 17,500 3.69 64,575
2017-08-17 Dumas Jacques (Chief ScientificOfficer) Sale 7,155 5.86 41,928
2017-06-13 Horn Patrick Taylor (Chief Medical Officer) Option Ex 10,000 2.03 20,299
2017-03-15 Gage L Patrick (Director) Buy 11,000 7.48 82,280
2017-02-09 Macdonald Guy (President and Chief Executive) Option Ex 30,378 2.90 88,096
2016-05-16 Macdonald Guy (President and Chief Executive) Option Ex 25,323 .87 22,031
2016-01-06 Macdonald Guy (President and Chief Executive) Option Ex 12,000 .87 10,440
2015-10-02 Gage L Patrick (Director) Option Ex 20,000 2.03 40,599
2015-09-08 Thompson John Craig (Chief Operating Officer) Sale 10,000 44.08 440,800
2015-09-08 Thompson John Craig (Chief Operating Officer) Option Ex 10,000 14.45 144,500
2015-09-01 Macdonald Guy (President and Chief Executive) Sale 10,000 41.57 415,700
2015-09-01 Macdonald Guy (President and Chief Executive) Option Ex 10,000 7.94 79,400
2015-08-24 Macdonald Guy (President and Chief Executive) Option Ex 12,000 .87 10,440
2015-08-14 Lubner David Charles (SVP and CFO) Sale 9,500 42.92 407,740
2015-08-14 Lubner David Charles (SVP and CFO) Option Ex 9,500 7.94 75,430
2015-08-13 Horn Patrick Taylor (Chief Medical Officer) Sale 10,000 44.69 446,900
2015-08-13 Horn Patrick Taylor (Chief Medical Officer) Option Ex 10,000 2.03 20,299
2015-08-12 Gage L Patrick (Director) Sale 15,000 45.00 675,000
2015-08-12 Gage L Patrick (Director) Option Ex 15,000 7.07 106,050
2015-08-06 Macdonald Guy (President and Chief Executive) Sale 30,000 43.65 1,309,500
2015-08-05 Thompson John Craig (Chief Operating Officer) Sale 10,000 46.31 463,100
2015-08-05 Thompson John Craig (Chief Operating Officer) Option Ex 10,000 14.45 144,500
2015-08-03 Macdonald Guy (President and Chief Executive) Sale 10,000 47.45 474,500
2015-08-03 Macdonald Guy (President and Chief Executive) Option Ex 10,000 7.94 79,400
2015-07-20 Macdonald Guy (President and Chief Executive) Sale 15,000 50.72 760,800
2015-07-14 Lubner David Charles (SVP and CFO) Sale 7,500 48.92 366,900
2015-07-14 Lubner David Charles (SVP and CFO) Option Ex 7,500 4.99 37,387
2015-07-13 Horn Patrick Taylor (Chief Medical Officer) Sale 10,000 48.93 489,300
2015-07-13 Horn Patrick Taylor (Chief Medical Officer) Option Ex 10,000 2.03 20,299
2015-07-06 Thompson John Craig (Chief Operating Officer) Sale 10,000 47.91 479,099
2015-07-06 Thompson John Craig (Chief Operating Officer) Option Ex 10,000 14.45 144,500
2015-07-01 Macdonald Guy (President and Chief Executive) Sale 10,000 47.92 479,200
2015-07-01 Macdonald Guy (President and Chief Executive) Option Ex 10,000 7.94 79,400
2015-06-15 Lubner David Charles (SVP and CFO) Sale 7,500 41.67 312,525
2015-06-15 Lubner David Charles (SVP and CFO) Option Ex 7,500 2.03 15,224
2015-06-15 Thompson John Craig (Chief Operating Officer) Sale 10,000 41.51 415,100
2015-06-15 Thompson John Craig (Chief Operating Officer) Option Ex 10,000 14.45 144,500
2015-06-12 Horn Patrick Taylor (Chief Medical Officer) Sale 10,000 41.72 417,200
2015-06-12 Horn Patrick Taylor (Chief Medical Officer) Option Ex 10,000 2.03 20,299
2015-06-12 Lubner David Charles (SVP and CFO) Sale 10,000 41.29 412,900
2015-06-08 Thompson John Craig (Chief Operating Officer) Sale 22,499 43.25 973,081
2015-06-08 Thompson John Craig (Chief Operating Officer) Option Ex 22,499 14.45 325,110
2015-06-01 Macdonald Guy (President and Chief Executive) Sale 16,087 41.92 674,367
2015-06-01 Macdonald Guy (President and Chief Executive) Option Ex 30,000 4.41 132,150
2015-05-15 Thompson John Craig (Chief Operating Officer) Sale 30,000 39.63 1,188,900
2015-05-15 Thompson John Craig (Chief Operating Officer) Option Ex 30,000 14.45 433,500
2015-05-14 Lubner David Charles (SVP and CFO) Sale 15,000 39.28 589,200
2015-05-14 Lubner David Charles (SVP and CFO) Option Ex 15,000 2.03 30,449
2015-05-11 Macdonald Guy (President and Chief Executive) Sale 20,000 41.51 830,200
2015-05-11 Macdonald Guy (President and Chief Executive) Option Ex 20,000 7.94 158,800
2015-03-26 Macdonald Guy (President and Chief Executive) Option Ex 20,000 .87 17,400
2015-03-02 Macdonald Guy (President and Chief Executive) Sale 10,000 39.28 392,849
2015-03-02 Macdonald Guy (President and Chief Executive) Option Ex 10,000 7.94 79,400
2015-02-02 Macdonald Guy (President and Chief Executive) Sale 10,000 35.51 355,100
2015-02-02 Macdonald Guy (President and Chief Executive) Option Ex 10,000 7.94 79,400
2015-01-20 Macdonald Guy (President and Chief Executive) Sale 34,135 36.59 1,248,965
2015-01-20 Macdonald Guy (President and Chief Executive) Option Ex 34,135 4.16 142,001
2014-10-02 Freund John Gordon (Director) Sale 105,588 20.87 2,203,410
2014-10-01 Freund John Gordon (Director) Sale 142,146 20.65 2,935,314
2014-09-30 Freund John Gordon (Director) Sale 56,618 20.17 1,141,871
2014-09-29 Freund John Gordon (Director) Sale 95,648 20.19 1,931,324
2014-09-23 Macdonald Guy (President and Chief Executive) Sale 10,000 18.47 184,660
2014-09-23 Macdonald Guy (President and Chief Executive) Option Ex 10,000 2.03 20,299
2014-09-17 Macdonald Guy (President and Chief Executive) Sale 10,000 18.00 180,000
2014-09-17 Macdonald Guy (President and Chief Executive) Option Ex 10,000 .87 8,700
2014-09-17 Freund John Gordon (Director) Sale 77,000 17.36 1,336,566
2014-09-16 Freund John Gordon (Director) Sale 67,356 17.03 1,147,140
2014-09-12 Freund John Gordon (Director) Sale 53,544 17.01 910,783
2014-09-11 Freund John Gordon (Director) Sale 2,100 17.00 35,708
2014-09-08 Freund John Gordon (Director) Sale 4,473 15.01 67,126
2014-09-05 Freund John Gordon (Director) Sale 12,227 15.01 183,527
2014-09-04 Freund John Gordon (Director) Sale 41,200 15.06 620,595
2014-09-03 Freund John Gordon (Director) Sale 142,100 15.04 2,137,184
2014-08-20 Macdonald Guy (President and Chief Executive) Sale 10,000 11.59 115,900
2014-08-20 Macdonald Guy (President and Chief Executive) Option Ex 10,000 .87 8,700
2014-08-05 Macdonald Guy (President and Chief Executive) Option Ex 25,000 .87 21,750
2014-07-18 Macdonald Guy (President and Chief Executive) Sale 15,000 10.61 159,105
2014-07-18 Macdonald Guy (President and Chief Executive) Option Ex 40,000 .87 34,800
2014-06-23 Freund John Gordon (Director) Sale 47,184 13.77 649,912
2014-06-20 Freund John Gordon (Director) Sale 82,716 13.65 1,128,907
2014-06-19 Freund John Gordon (Director) Sale 70,100 13.08 916,697
2014-06-17 Lubner David Charles (SVP and CFO) Sale 13,530 12.51 169,260
2014-06-17 Macdonald Guy (President and Chief Executive) Sale 15,000 12.28 184,230
2014-06-17 Macdonald Guy (President and Chief Executive) Option Ex 15,000 .87 13,050
2014-06-13 Gage L Patrick (Director) Buy 500 11.42 5,710
2014-06-05 Gage L Patrick (Director) Buy 975 10.28 10,026
2014-06-04 Gage L Patrick (Director) Buy 500 10.05 5,025
2014-05-28 Gage L Patrick (Director) Buy 850 10.70 9,095
2014-05-19 Gullans Steven R. Ph.d. (Director) Buy 25,000 9.24 230,975
2014-05-19 Macdonald Guy (President and Chief Executive) Sale 15,000 9.00 135,000
2014-05-19 Macdonald Guy (President and Chief Executive) Option Ex 15,000 .87 13,050
2014-05-14 Gage L Patrick (Director) Buy 5,000 9.25 46,250
2014-04-14 Macdonald Guy (President and Chief Executive) Sale 15,000 9.69 145,350
2014-04-14 Macdonald Guy (President and Chief Executive) Option Ex 15,000 .87 13,050
2014-03-20 Sutcliffe Joyce A. (Senior Vice President, Biology) Sale 11,494 12.41 142,640
2014-03-06 Lubner David Charles (SVP and CFO) Sale 4,510 13.65 61,561
2014-02-20 Sutcliffe Joyce A. (Senior Vice President, Biology) Sale 11,494 14.00 160,916
2014-02-12 Lubner David Charles (SVP and CFO) Sale 4,506 13.92 62,723
2014-02-10 Macdonald Guy (President and Chief Executive) Sale 15,000 14.42 216,300
2014-02-10 Macdonald Guy (President and Chief Executive) Option Ex 15,000 .87 13,050
2014-02-07 Lubner David Charles (SVP and CFO) Sale 9,928 14.22 141,176
2014-02-07 Lubner David Charles (SVP and CFO) Option Ex 88,391 1.64 145,226
2014-02-05 Sutcliffe Joyce A. (Senior Vice President, Biology) Sale 11,494 13.93 160,111
2014-01-17 Sutcliffe Joyce A. (Senior Vice President, Biology) Option Ex 51,724 .87 44,999
2013-09-18 Watson James F (10% Owner) Sale 100,000 10.20 1,019,999
2013-09-17 Watson James F (10% Owner) Sale 8,204 9.48 77,773
2013-09-16 Watson James F (10% Owner) Sale 45,264 9.22 417,334
2013-03-25 Howard Paul Anthony (10% Owner) Buy 285,713 7.00 1,999,991
2013-03-25 Excel Medical Ventures, Llc (10% Owner) Buy 496,121 7.00 3,472,847
2013-03-25 Gullans Steven R. Ph.d. (Director) Buy 496,121 7.00 3,472,847
2013-03-25 Skyline Venture Management Iv, Llc (10% Owner) Buy 681,012 7.00 4,767,084
2013-03-25 Freund John Gordon (Director) Buy 681,012 7.00 4,767,084
2013-03-25 Kania Edwin M Jr (10% Owner) Buy 491,824 7.00 3,442,768
2013-03-25 Baruch Thomas R (10% Owner) Buy 642,857 7.00 4,499,999
2013-03-20 Fmr Llc (Other) Buy 642,857 7.00 4,499,999

Insider trading activities including stock purchases, stock sales, and option exercises of TTPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tetraphase Pharmaceuticals Inc (symbol TTPH, CIK number 1373707) see the Securities and Exchange Commission (SEC) website.